{"product_id":"harvard-pulmonary-and-critical-care-medicine-2025","title":"Harvard Pulmonary and Critical Care Medicine 2025","description":"\u003ch1 class=\"entry-title\"\u003eHarvard Pulmonary and Critical Care Medicine 2025\u003c\/h1\u003e\n\u003cstrong\u003e 56 videos + 49 pdfs, size: 18.8 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eComprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003ePulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies. The 2025 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.\u003c\/em\u003e\n\u003cbr\u003e\u003ch2\u003e\u003cb\u003e\u003cstrong\u003eOVERVIEW\u003c\/strong\u003e\u003c\/b\u003e\u003c\/h2\u003e\u003cbr\u003eThis comprehensive course provides education and updates to optimize your care of patients with:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIPF\u003c\/li\u003e\n\u003cli\u003eARDS\u003c\/li\u003e\n\u003cli\u003eSarcoidosis\u003c\/li\u003e\n\u003cli\u003eLung transplantation\u003c\/li\u003e\n\u003cli\u003eBronchiectasis\u003c\/li\u003e\n\u003cli\u003eCystic fibrosis\u003c\/li\u003e\n\u003cli\u003eLung nodules\u003c\/li\u003e\n\u003cli\u003eLung cancer\u003c\/li\u003e\n\u003cli\u003eSepsis\u003c\/li\u003e\n\u003cli\u003ePleural disease\u003c\/li\u003e\n\u003cli\u003ePneumonia\u003c\/li\u003e\n\u003cli\u003eTuberculosis\u003c\/li\u003e\n\u003cli\u003eThromboembolism\u003c\/li\u003e\n\u003cli\u003eChronic cough\u003c\/li\u003e\n\u003cli\u003eCOPD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003eAsthma\u003c\/li\u003e\n\u003cli\u003eOccupational and environmental lung disease\u003c\/li\u003e\n\u003cli\u003eInterstitial lung disease\u003c\/li\u003e\n\u003cli\u003eGERD\u003c\/li\u003e\n\u003cli\u003eNeurologic issues in the ICU\u003c\/li\u003e\n\u003cli\u003eSleep-disordered breathing\u003c\/li\u003e\n\u003cli\u003ePost-acute sequelae of COVID-19\u003c\/li\u003e\n\u003cli\u003eSurgical emergencies\u003c\/li\u003e\n\u003cli\u003eAtypical mycobacterial disease\u003c\/li\u003e\n\u003cli\u003ePulmonary hypertension\u003c\/li\u003e\n\u003cli\u003eCardiopulmonary disorders\u003c\/li\u003e\n\u003cli\u003eComplications from cardiac arrest\u003c\/li\u003e\n\u003cli\u003eHypersensitivity pneumonitis\u003c\/li\u003e\n\u003cli\u003eAcute respiratory failure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003e\u003cstrong\u003eREASONS TO ATTEND IN 2025\u003c\/strong\u003e\u003c\/b\u003e\u003c\/h2\u003e\u003cbr\u003eAll sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe most current guidelines for treating sepsis\u003c\/li\u003e\n\u003cli\u003eEvidence-based treatment of ARDS\u003c\/li\u003e\n\u003cli\u003eState of the art in interventional pulmonology\u003c\/li\u003e\n\u003cli\u003eHigh-flow oxygen therapy for respiratory failure\u003c\/li\u003e\n\u003cli\u003eUpdates on biologics in asthma and other lung disease\u003c\/li\u003e\n\u003cli\u003eNew concepts in the use of vasopressors in septic shock\u003c\/li\u003e\n\u003cli\u003eNew drugs and combinations in pulmonary hypertension\u003c\/li\u003e\n\u003cli\u003eNew evidence on sedation, analgesia, and early mobility in the ICU\u003c\/li\u003e\n\u003cli\u003ePoint-of-care pulmonary ultrasound in the intensive care unit\u003c\/li\u003e\n\u003cli\u003eLung microbiome: emerging implications for lung health\u003c\/li\u003e\n\u003cli\u003eEmerging evidence for targeted temperature management\u003c\/li\u003e\n\u003cli\u003eEvaluating occupational and environmental lung disease\u003c\/li\u003e\n\u003cli\u003eSteroid-sparing agents for interstitial lung disease\u003c\/li\u003e\n\u003cli\u003ePulmonary embolus: the latest treatment strategies\u003c\/li\u003e\n\u003cli\u003eState-of-the-art management of the critically ill patient\u003c\/li\u003e\n\u003cli\u003eGuidance to conduct end-of-life discussions\u003c\/li\u003e\n\u003cli\u003eUpdates in pulmonary pathology\u003c\/li\u003e\n\u003cli\u003eNew treatment options in cystic fibrosis\u003c\/li\u003e\n\u003cli\u003eHandling neurologic and surgical emergencies in the medical ICU\u003c\/li\u003e\n\u003cli\u003eNew approaches that improve outcomes for patients with unexplained chronic cough\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eParticipants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cem\u003eOptional Half-Day Program\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003e(No additional fees apply)\u003c\/em\u003e\n\u003cbr\u003e\u003ch2\u003e\u003cb\u003e\u003cstrong\u003eSleep Medicine for Pulmonologists\u003c\/strong\u003e\u003c\/b\u003e\u003c\/h2\u003e\u003cbr\u003eThis sleep medicine program provides pulmonologists the opportunity to learn about recent advances in Sleep Medicine and how they impact clinical practice.\u003cbr\u003e\u003cbr\u003eOffered on Friday afternoon, May 2, participants of Pulmonology and Critical Care Medicine 2025 can participate in this half-day program at no additional cost.\u003cbr\u003e\u003cbr\u003eHighlights of this practical, interactive educational experience include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eUpdates for diagnosis and management of sleep-disordered breathing\u003c\/li\u003e\n\u003cli\u003eState-of-the-art management algorithms\u003c\/li\u003e\n\u003cli\u003eNew technologies vs. the “gold standard” polysomnogram\u003c\/li\u003e\n\u003cli\u003eReimbursement and telemedicine\u003c\/li\u003e\n\u003cli\u003eImproved adherence to therapy\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eParticipants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.\u003cbr\u003e\u003ch2\u003e\u003cb\u003e\u003cstrong\u003eOPTIMIZED FOR REMOTE EDUCATION\u003c\/strong\u003e\u003c\/b\u003e\u003c\/h2\u003e\u003cbr\u003eThe 2025 program has been enhanced for distance learning. In addition to being live streamed, all sessions will be recorded and made available to participants for online viewing for 90 days after the end of the course.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDay 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.mp4\u003cbr\u003eDay 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.pdf\u003cbr\u003eDay 1 Cystic Fibrosis Understanding CFTR and New Treatment.mp4\u003cbr\u003eDay 1 Cystic Fibrosis Understanding CFTR and New Treatment.pdf\u003cbr\u003eDay 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.mp4\u003cbr\u003eDay 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.pdf\u003cbr\u003eDay 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.mp4\u003cbr\u003eDay 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.pdf\u003cbr\u003eDay 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.mp4\u003cbr\u003eDay 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.pdf\u003cbr\u003eDay 1 GERD in Pulmonology.mp4\u003cbr\u003eDay 1 GERD in Pulmonology.pdf\u003cbr\u003eDay 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.mp4\u003cbr\u003eDay 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.pdf\u003cbr\u003eDay 1 Looking Deeper Patterns and Insights from Chest Radiology.mp4\u003cbr\u003eDay 1 Looking Deeper Patterns and Insights from Chest Radiology.pptx\u003cbr\u003eDay 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.mp4\u003cbr\u003eDay 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.pdf\u003cbr\u003eDay 1 Pulmonary Pathology Interstitial Lung Disease.mp4\u003cbr\u003eDay 1 Pulmonary Pathology Interstitial Lung Disease.pdf\u003cbr\u003eDay 1 Q \u0026amp; A Session with Speakers 1.mp4\u003cbr\u003eDay 1 Q \u0026amp; A Session with Speakers 2.mp4\u003cbr\u003eDay 1 Treatment Challenges of Pulmonary Sarcoidosis.mp4\u003cbr\u003eDay 1 Treatment Challenges of Pulmonary Sarcoidosis.pdf\u003cbr\u003eDay 2 After the ICU Post-ICU Care Syndrome and Recovery.mp4\u003cbr\u003eDay 2 After the ICU Post-ICU Care Syndrome and Recovery.pdf\u003cbr\u003eDay 2 Approach to Empiric Antibiotics in the ICU.mp4\u003cbr\u003eDay 2 Approach to Empiric Antibiotics in the ICU.pdf\u003cbr\u003eDay 2 Approach to the Immunocompromised Critically Ill Patient.mp4\u003cbr\u003eDay 2 Approach to the Immunocompromised Critically Ill Patient.pdf\u003cbr\u003eDay 2 ARDS State-of-the-Art Strategies to Protect the Lung.mp4\u003cbr\u003eDay 2 ARDS State-of-the-Art Strategies to Protect the Lung.pdf\u003cbr\u003eDay 2 Fluid Responsiveness.mp4\u003cbr\u003eDay 2 Fluid Responsiveness.pdf\u003cbr\u003eDay 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.mp4\u003cbr\u003eDay 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.pdf\u003cbr\u003eDay 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.mp4\u003cbr\u003eDay 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.pdf\u003cbr\u003eDay 2 Novel Ventilator Modes The Hype and the Reality.mp4\u003cbr\u003eDay 2 Novel Ventilator Modes The Hype and the Reality.pdf\u003cbr\u003eDay 2 Q \u0026amp; A with Speakers 1.mp4\u003cbr\u003eDay 2 Q \u0026amp; A with Speakers 2.mp4\u003cbr\u003eDay 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).mp4\u003cbr\u003eDay 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).pdf\u003cbr\u003eDay 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.mp4\u003cbr\u003eDay 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.pdf\u003cbr\u003eDay 2 Vasopressors in Septic Shock Old Friends and New.mp4\u003cbr\u003eDay 2 Vasopressors in Septic Shock Old Friends and New.pdf\u003cbr\u003eDay 3 Advanced Cardiac Support in the ICU.mp4\u003cbr\u003eDay 3 Advanced Cardiac Support in the ICU.pdf\u003cbr\u003eDay 3 Common Neurologic Issues in the ICU.mp4\u003cbr\u003eDay 3 Common Neurologic Issues in the ICU.pdf\u003cbr\u003eDay 3 New Approaches to the Unexplained Chronic Cough.mp4\u003cbr\u003eDay 3 New Approaches to the Unexplained Chronic Cough.pdf\u003cbr\u003eDay 3 Occupational and Environmental Lung Disease.mp4\u003cbr\u003eDay 3 Occupational and Environmental Lung Disease.pdf\u003cbr\u003eDay 3 Palliative Care in Advanced Lung Disease.mp4\u003cbr\u003eDay 3 Palliative Care in Advanced Lung Disease.pdf\u003cbr\u003eDay 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.mp4\u003cbr\u003eDay 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.pdf\u003cbr\u003eDay 3 Point-of-Care Ultrasound in the Intensive Care Unit.mp4\u003cbr\u003eDay 3 Point-of-Care Ultrasound in the Intensive Care Unit.pdf\u003cbr\u003eDay 3 Prognosis and Uncertainty in the ICU.mp4\u003cbr\u003eDay 3 Q \u0026amp; A with Speakers 1.mp4\u003cbr\u003eDay 3 Q \u0026amp; A with Speakers 2.mp4\u003cbr\u003eDay 3 Surgical Emergencies in the Medical ICU.mp4\u003cbr\u003eDay 3 Surgical Emergencies in the Medical ICU.pdf\u003cbr\u003eDay 3 The Microbiome and Lung Disease.mp4\u003cbr\u003eDay 3 The Microbiome and Lung Disease.pdf\u003cbr\u003eDay 3 TTM and Neuroprognostication After Cardiac Arrest.mp4\u003cbr\u003eDay 3 TTM and Neuroprognostication After Cardiac Arrest.pdf\u003cbr\u003eDay 4 A Strategic Approach to the Management of Pulmonary Nodules.pdf\u003cbr\u003eDay 4 Aspergillus Lung Disease.mp4\u003cbr\u003eDay 4 Aspergillus Lung Disease.pdf\u003cbr\u003eDay 4 Asthma What’s New in 2025.mp4\u003cbr\u003eDay 4 Asthma What’s New in 2025.pdf\u003cbr\u003eDay 4 COPD 2025.mp4\u003cbr\u003eDay 4 COPD 2025.pdf\u003cbr\u003eDay 4 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond.mp4\u003cbr\u003eDay 4 Interventional Pulmonology in 2025.mp4\u003cbr\u003eDay 4 New Therapeutics in Lung Disease The Age of Immunotherapy.mp4\u003cbr\u003eDay 4 New Therapeutics in Lung Disease The Age of Immunotherapy.pdf\u003cbr\u003eDay 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.mp4\u003cbr\u003eDay 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.pdf\u003cbr\u003eDay 4 Pleural Disease 2025 Updates.mp4\u003cbr\u003eDay 4 Pleural Disease 2025 Updates.pdf\u003cbr\u003eDay 4 Q \u0026amp; A with Speakers 1.mp4\u003cbr\u003eDay 4 Q \u0026amp; A with Speakers 2.mp4\u003cbr\u003eDay 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.mp4\u003cbr\u003eDay 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.pdf\u003cbr\u003eDay 4 Tuberculosis in 2025.mp4\u003cbr\u003eDay 4 Tuberculosis in 2025.pdf\u003cbr\u003eDay 5 Complex Sleep Apnea 2025.pdf\u003cbr\u003eDay 5 Noninvasive Ventilation.pdf\u003cbr\u003eDay 5 Obstructive Sleep Apnea.pdf\u003cbr\u003eDay 5 Pulmonary Embolism An Update.mp4\u003cbr\u003eDay 5 Pulmonary Hypertension Categorization and Evaluation.mp4\u003cbr\u003eDay 5 Pulmonary Hypertension Management.pdf\u003cbr\u003eDay 5 Sleep Diagnostics.pdf\u003cbr\u003eDay 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.mp4\u003cbr\u003eDay 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.pdf\u003cbr\u003eDay 5 Vasculitis and ANCA.mp4\u003cbr\u003eDay 5 Vasculitis and ANCA.pdf\u003cbr\u003eDay 5.mp4\u003cbr\u003ePulmonary Schedule.pdf\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954480222306,"sku":"MED-AMB04192","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Pulmonary-and-Critical-Care-Medicine-2025_23fa36f4-7eaa-47af-975b-91888b313a26.png?v=1779377579","url":"https:\/\/meducourse.com\/products\/harvard-pulmonary-and-critical-care-medicine-2025","provider":"Meducourse","version":"1.0","type":"link"}